Valeo Pharma is a fast growing pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada with a focus on Respirology/Allergy, Ophthalmology and Specialty Products. Headquartered in Kirkland, Quebec, Valeo Pharma has the full capability and complete infrastructure to register and properly manage its growing product portfolio through all stages of commercialization.
Valeo Pharma Inc.
TSX:VPH
0.51
cad
Volume 24500
Change
4.08 %
Prev. Close 0.49 cad
OTCQB:VPHIF
0.32
usd
Volume 2000
Change
0.00 %
Prev. Close 0.32 usd
Disclaimer: All stock information on InvestorIntel.com is currently being fed from multiple sources and is updated automatically every 10-minutes. The information on this site is for information purposes only and InvestorIntel Corp. is neither responsible nor liable for the accuracy of this data.
InvestorIntel Features on Valeo Pharma Inc.
-
Valeo Pharma on a significant upswing with recent Health Canada approvals
In a new InvestorIntel interview Peter Clausi speaks with Steve Saviuk, CEO of Valeo Pharma Inc. (CSE: VPH…
-
Valeo Pharma’s approval and launch of immune support product line Redesca and Redesca HP anticipated to impact first half 2021 revenue
Most investors know that the pharmaceutical industry is a huge and mostly very profitable industry. What they may…
-
Kozak on how Valeo Pharma’s innovative natural health-based product lines are carving their niche in specialty pharmaceuticals
“Valeo is focused on those therapeutic fields where a relatively small number of general practitioners or specialist physicians…